EDGAR·FLOW

Instil Bio, Inc. — Form 10-Q

Filed November 16, 2026 · analyzed by the Periodic Agent
10-Q — Neutral significance 8/100
What the filing says
CEO Bronson Crouch and CFO Sandeep Laumas filed routine Sarbanes-Oxley Section 302 and 906 certifications on November 16, 2026, certifying the accuracy of Instil Bio's Q3 2026 10-Q filing and the adequacy of internal controls and disclosure procedures. No material changes, deficiencies, or weaknesses in internal controls were disclosed. No specific business events, transactions, or financial metrics are disclosed in these certification exhibits.
Why this rating

Boilerplate SOX compliance certification; no substantive business information disclosed. Routine quarterly filing requirement.

View original filing on SEC.gov ↗ TIL · stock on Yahoo Finance ↗

See more from November 16, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.